Dual-target inhibitors of mycobacterial aminoacyl-tRNA synthetases among N-benzylidene-N'-thiazol-2-yl-hydrazines

Tuesday, 18 February 2020

Recently, the article dedicated to the development of dual-targeted inhibitors of mycobacterial aminoacyl-tRNA synthetases among N-benzylidene-N'-thiazol-2-yl-hydrazines has been...

Benzaldehyde thiosemicarbazone derivatives against replicating and nonreplicating Mycobacterium tuberculosis

Tuesday, 28 May 2019

Recently, the article dedicated to the development of antituberculosis agents based on benzaldehyde thiosemicarbazone derivatives has been published.

Abstract:

In this article, we...

Participation in FEBS 2018 Advanced Courses "Ligand-binding theory and practice"

Sunday, 15 July 2018

Young scientist from the Department of Medicinal Chemistry of the Institute of Molecular Biology and Genetics of the NAS of Ukraine, Galyna Volynets, participated in FEBS Advanced Course...

Participation in the 43rd FEBS Congress

Sunday, 15 July 2018

Young scientific researcher at the Department of Medicinal Chemistry of the Institute of Molecular Biology and Genetics, Maryna Kuperman, has attended the FEBS Congress "Biochemistry...

News and Events

Dual-target inhibitors of mycobacterial aminoacyl-tRNA synthetases among N-benzylidene-N'-thiazol-2-yl-hydrazines

Benzaldehyde thiosemicarbazone derivatives against replicating and nonreplicating Mycobacterium tuberculosis

Participation in FEBS 2018 Advanced Courses "Ligand-binding theory and practice"

Participation in the 43rd FEBS Congress

Our research:

FGFR1 Inhibitors

CK2 Inhibitors

ASK1 Inhibitors

Molecular Design

Fluorescent Probes